| 英文名称 | 中文名称 | CAS | MF |
|
FMOC-(S)-3-AMINO-3-(2-NAPHTHYL)-PROPIONIC ACID
|
FMOC-(S)-3-氨基-3-(2-萘基)-丙酸
|
507472-11-9
|
C28H23NO4
|
|
FMOC-(S)-3-AMINO-3-(2-FLUORO-PHENYL)-PROPIONIC ACID
|
FMOC-(S)-3-氨基-3-(2-氟苯基)-丙酸
|
507472-13-1
|
C24H20FNO4
|
|
FMOC-(S)-3-AMINO-3-(3-FLUORO-PHENYL)-PROPIONIC ACID
|
FMOC-(S)-3-氨基-3-(3-氟苯基)-丙酸
|
507472-14-2
|
C24H20FNO4
|
|
FMOC-(S)-3-AMINO-3-(2-CHLORO-PHENYL)-PROPIONIC ACID
|
FMOC-(S)-3-氨基-3-(2-氯苯基)-丙酸
|
507472-15-3
|
C24H20ClNO4
|
|
FMOC-(S)-3-AMINO-3-(3-CHLORO-PHENYL)-PROPIONIC ACID
|
FMOC-(S)-3-氨基-3-(3-氯苯基)-丙酸
|
507472-16-4
|
C24H20ClNO4
|
|
FMOC-(S)-3-AMINO-3-(2-BROMO-PHENYL)-PROPIONIC ACID
|
FMOC-(S)-3-氨基-3-(2-溴苯基)-丙酸
|
507472-17-5
|
C24H20BrNO4
|
|
FMOC-(S)-3-AMINO-3-(3-BROMO-PHENYL)-PROPIONIC ACID
|
FMOC-(S)-3-氨基-3-(3-溴苯基)-丙酸
|
507472-18-6
|
C24H20BrNO4
|
|
FMOC-(S)-3-AMINO-3-(2-TRIFLUOROMETHYL-PHENYL)-PROPIONIC ACID
|
FMOC-(S)-3-氨基-3-(2-三氟甲基苯基)-丙酸
|
507472-19-7
|
C25H20F3NO4
|
|
FMOC-(S)-3-AMINO-3-(3-TRIFLUOROMETHYL-PHENYL)-PROPIONIC ACID
|
FMOC-(S)-3-氨基-3-(3-三氟甲基苯基)-丙酸
|
507472-20-0
|
C25H20F3NO4
|
|
FMOC-(S)-3-AMINO-3-(4-TRIFLUOROMETHYL-PHENYL)-PROPIONIC ACID
|
FMOC-(S)-3-氨基-3-(4-三氟甲基苯基)-丙酸
|
507472-21-1
|
C25H20F3NO4
|
|
FMOC-(S)-3-AMINO-3-(3-CYANO-PHENYL)-PROPIONIC ACID
|
(S)-FMOC-Β-PHE(3-CN)-OH
|
507472-23-3
|
C25H20N2O4
|
|
FMOC-(S)-3-AMINO-3-(4-CYANO-PHENYL)-PROPIONIC ACID
|
FMOC-(S)-3-氨基-3-(4-苯腈基)丙酸
|
507472-24-4
|
C25H20N2O4
|
|
FMOC-(S)-3-AMINO-3-(2-NITRO-PHENYL)-PROPIONIC ACID
|
FMOC-(S)-3-氨基-3-(2-硝基苯基)-丙酸
|
507472-25-5
|
C24H20N2O6
|
|
FMOC-(R)-3-AMINO-3-(4-NITRO-PHENYL)-PROPIONIC ACID
|
FMOC-(R)-3-氨基-3-(4-硝基苯基)-丙酸
|
507472-26-6
|
C24H20N2O6
|
|
FMOC-(R)-3-AMINO-3-(2-METHYL-PHENYL)-PROPIONIC ACID
|
FMOC-(R)-3-氨基-3-(2-甲基苯基)-丙酸
|
507472-27-7
|
C25H23NO4
|
|
FMOC-(R)-3-AMINO-3-(3-METHYL-PHENYL)-PROPIONIC ACID
|
FMOC-(R)-3-氨基-3-(3-甲基苯基)-丙酸
|
507472-28-8
|
C25H23NO4
|
|
2(1H)-Pyrimidinone,6-methoxy-1-methyl-(9CI)
|
|
507472-97-1
|
C6H8N2O2
|
|
2H-1,2,3-Triazole-4-carboxylicacid,5-methyl-,ethylester(9CI)
|
|
507473-06-5
|
C6H9N3O2
|
|
2,3-DiMethoxy-5-nitropyridine
|
2,3-DiMethoxy-5-nitropyridine
|
507473-22-5
|
C7H8N2O4
|
|
1H-Pyrrole-2,5-dione,3-hydrazino-1-propyl-(9CI)
|
|
507473-26-9
|
C7H11N3O2
|
|
2H-1,2-Oxazine, 3,4-dihydro-2-hydroxy-4,4,6-trimethyl- (9CI)
|
|
507473-28-1
|
C7H13NO2
|
|
TPCA-1
|
5-(4-氟苯基)-2-脲基噻吩-3-甲酰胺
|
507475-17-4
|
C12H10FN3O2S
|
|
5-TERT-BUTYL-1,3,4-THIADIAZOLE-2-CARBOXYLIC ACID ETHYL ESTER
|
5-叔丁基-1,3,4-噻二唑-2-羧酸乙酯
|
507476-05-3
|
C9H14N2O2S
|
|
5-broMoquinoline-8-carbonitrile
|
5-溴喹啉-8-甲腈
|
507476-70-2
|
C10H5BrN2
|
|
1(2H)-Naphthalenone, 2-fluoro-3,4-dihydro-5-hydroxy-
|
2-氟-5-羟基-3,4-二氢萘-1(2H)-酮
|
507477-10-3
|
C10H9FO2
|
|
Benzo[b]thiophen-4(5H)-one, 5-fluoro-6,7-dihydro-
|
|
507477-13-6
|
C8H7FOS
|
|
4H-1-Benzopyran-4-one, 3-fluoro-2,3-dihydro-
|
|
507477-14-7
|
C9H7FO2
|
|
1H-Inden-1-one, 2-fluoro-2,3-dihydro-4-methoxy-
|
|
507477-15-8
|
C10H9FO2
|
|
ICBr
|
OC1177, 5(6)-溴-3-(二氰基亚甲基)茚-1-酮混合物
|
507484-47-1
|
C12H5BrN2O
|
|
2-(6-chloro-2,3-Dihydro-3-oxo-1H-inden-ylidene)-propanedinitrile
|
6-氯-3-(二氰基亚甲基)靛酮
|
507484-48-2
|
C12H5ClN2O
|
|
2-(6-fluoro-3-oxo-2,3-dihydro-1H-inden-1-ylidene)malononitrile
|
6-氟-3-(二氰基亚甲基)靛酮
|
507484-54-0
|
C12H5FN2O
|
|
2-(6-methoxy-3-oxo-2,3-dihydro-1H-inden-1-ylidene)malononitrile
|
6-甲氧基-3-(二氰基亚甲基)靛酮
|
507484-59-5
|
C13H8N2O2
|
|
2-(6-methyl-3-oxo-2,3-dihydro-1H-inden-1-ylidene)malononitrile
|
6-甲基-3-(二氰基亚甲基)靛酮
|
507484-61-9
|
C13H8N2O
|
|
1-ACETYL-3(5)-DIFLUOROMETHYL-5(3)-PHENYLPYRAZOLE
|
1-(3-(二氟甲基)-5-苯基-1H-吡唑-1-基)乙烷-1-酮
|
507485-96-3
|
C12H10F2N2O
|
|
1H-Indole-3-carboxamide,2-amino-1-ethyl-(9CI)
|
|
507487-47-0
|
C11H13N3O
|
|
7-Chloromethyloxy-carbonyloxy-6-(5-chloropyridin-2-yl)-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
|
7-Chloromethyloxy-carbonyloxy-6-(5-chloropyridin-2-yl)-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one
|
508169-18-4
|
C13H8Cl2N4O4
|
|
1-[4-BROMO-2-(HYDROXYMETHYL)PHENYL]-4-(DIMETHYLAMINO)-1-(4-FLUOROPHENYL) BUTAN-1-OL HYDROCHLORIDE
|
|
508169-73-1
|
C19H24BrClFNO2
|
|
1,2-Cyclohexanediol, 1-(aminomethyl)-, (1R,2R)-rel- (9CI)
|
|
508170-84-1
|
C7H15NO2
|
|
1,2-Cyclohexanediol, 1-(aminomethyl)-, (1R,2S)-rel- (9CI)
|
|
508170-86-3
|
C7H15NO2
|
|
2H-Pentaleno[1,6-gh]pyrrolizin-2-one,decahydro-,(3R,5aR,7aR,9aS,9bR)-rel-(9CI)
|
|
508171-25-3
|
C12H17NO
|
|
Cyanamide, (3-hydroxyphenyl)methyl- (9CI)
|
|
508174-21-8
|
C8H8N2O
|
|
Cyanamide, (3-methoxyphenyl)methyl- (9CI)
|
|
508174-24-1
|
C9H10N2O
|
|
Benzenemethanamine, 4-fluoro-3-methoxy- (9CI)
|
4-氟-3-甲氧基卞胺
|
508177-67-1
|
C8H10FNO
|
|
Diisononyl Cyclohexanedicarboxylate (Mixture of isoMers)
|
环己二甲酸二异壬酯 (异构体混合物)
|
508181-38-2
|
C78H144O12
|
|
3-(2-methoxyphenyl)-4,5-dihydroisoxazole-5-carboxylic acid(SALTDATA: FREE)
|
3-(2-甲氧基-苯基)-4,5-二氢-异恶唑-5-羧酸
|
508182-19-2
|
C11H11NO4
|
|
Ganoderic acid LM2
|
灵芝酸LM2
|
508182-41-0
|
C30H42O7
|
|
2-[2,5-dimethyl-3-({[4-(4-morpholinyl)phenyl]imino}methyl)-1H-pyrrol-1-yl]-N-phenyl-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide
|
|
508185-02-2
|
C32H34N4O2S
|
|
1,3-PIPERIDINEDICARBOXAMIDE, N1-(2,3-DI-2-FURANYL-6-QUINOXALINYL)-N3,N3-DIETHYL-
|
|
508186-08-1
|
C27H29N5O4
|
|
1-(2,3-Di(thiophen-2-yl)quinoxalin-6-yl)-3-(2-methoxyethyl)urea
|
1-(2,3-二(噻吩-2-基)喹啉-6-基)-3-(2-甲氧基乙基)脲
|
508186-14-9
|
C20H18N4O2S2
|
|
5-{[1-(3-iodophenyl)-2,5-dimethyl-1H-pyrrol-3-yl]methylidene}-2-thioxodihydropyrimidine-4,6(1H,5H)-dione
|
|
508186-85-4
|
C17H14IN3O2S
|
|
2-(4-Bromo-2,6-dimethylphenoxy)acetonitrile
|
2-(4-BROMO-2,6-DIMETHYLPHENOXY)ACETONITRILE
|
508189-19-3
|
C10H10BrNO
|
|
1,2,3-Oxadiazolium,2,5-dihydro-5-oxo-3-phenyl-,innersalt(9CI)
|
|
508191-77-3
|
C8H7N2O2+
|
|
N-4-Piperidinyl-4-piperidinamine
|
N-4-哌啶基-4-哌啶胺
|
508201-22-7
|
C10H21N3
|
|
1H-Pyrrolo[2,3-c]pyridine-5-carboxamide,N-1-azabicyclo[2.2.1]hept-3-yl-(9CI)
|
|
508201-96-5
|
C14H16N4O
|
|
Benzonitrile, 2,3-difluoro-4-methyl- (9CI)
|
2,3-二氟-4-甲基苯腈
|
508203-48-3
|
C8H5F2N
|
|
Benzenemethanamine, 2-fluoro-5-methoxy-N,N-dimethyl- (9CI)
|
|
508204-26-0
|
C10H14FNO
|
|
2-Azabicyclo[2.2.2]octane-3-carboxylic acid, 5,6-dihydroxy-, ethyl ester, (1S,3S,4S,5S,6R)- (9CI)
|
|
508205-07-0
|
C10H17NO4
|
|
1H-Pyrrolo[2,3-c]pyridine-5-carboxamide,N-2-azabicyclo[2.2.1]hept-5-yl-(9CI)
|
|
508208-62-6
|
C14H16N4O
|
|
1H-Pyrrolo[2,3-c]pyridine-5-carboxamide,N-2-azabicyclo[2.2.1]hept-6-yl-(9CI)
|
|
508208-63-7
|
C14H16N4O
|
|
(3S, 4R)-1-AZA-BICYCLO[2.2.1]HEPT-3-YLAMINE
|
(3S,4R)-1-氮杂双环并2.2.1]庚-3-胺
|
508209-67-4
|
C6H12N2
|
|
Methyl 2-(benzyloxy)-5-nitrobenzenecarboxylate
|
METHYL 2-(BENZYLOXY)-5-NITROBENZENECARBOXYLATE
|
508211-52-7
|
C15H13NO5
|
|
Cyclopropanecarboxylic acid, 2-(hydroxymethyl)-3-methyl-, methyl ester,
|
|
508216-81-7
|
C7H12O3
|
|
Cyclopropanecarboxylic acid, 2-(hydroxymethyl)-3-methyl-, methyl ester,
|
|
508216-83-9
|
C7H12O3
|
|
Cyclopropanecarboxylic acid, 2-formyl-3-methyl-, methyl ester, (1R,2S,3S)-rel- (9CI)
|
|
508216-90-8
|
C7H10O3
|
|
Cyclopropanecarboxylic acid, 2-formyl-3-methyl-, methyl ester, (1R,2S,3R)-rel- (9CI)
|
|
508216-92-0
|
C7H10O3
|
|
Cyclopropanecarboxylic acid, 2-(1H-imidazol-4-yl)-, (1R,2S)-rel- (9CI)
|
|
508217-13-8
|
C7H8N2O2
|
|
Phenol, 4-ethenyl-2,6-diethoxy- (9CI)
|
|
508220-53-9
|
C12H16O3
|
|
tert-Butyl 2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenylcarbamate
|
4-(BOC-AMINO)-3-METHYLPHENYLBORONIC ACID, PINACOL ESTER
|
508223-54-9
|
C18H28BNO4
|
|
4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(trifluoromethyl)aniline
|
4-(4,4,5,5-四甲基-1,3,2-二氧杂硼烷-2-基)-2-(三氟甲基)苯胺
|
508223-55-0
|
C13H17BF3NO2
|
|
1,4,5,6-Tetrahydro-cyclopentapyrazol-3-ylaMine
|
1,4,5,6-TETRAHYDRO-CYCLOPENTAPYRAZOL-3-YL-AMINE
|
508229-66-1
|
C6H9N3
|
|
Cyclopropanecarboxamide, N-(1,4,5,6-tetrahydro-3-cyclopentapyrazolyl)- (9CI)
|
|
508229-82-1
|
C10H13N3O
|
|
Benzamide, 3-fluoro-N-(1,4,5,6-tetrahydro-3-cyclopentapyrazolyl)- (9CI)
|
|
508230-01-1
|
C13H12FN3O
|
|
2(1H)-Quinoxalinone,6-amino-1,3-dimethyl-(9CI)
|
|
508230-24-8
|
C10H11N3O
|
|
Vortioxetine
|
沃替西汀
|
508233-74-7
|
C18H22N2S
|
|
Vortioxetine Impurity 2
|
Vortioxetine Impurity 2
|
508233-75-8
|
C18H22N2S
|
|
1-[2-[(2,6-diMethylphenyl)thio]phenyl]- Piperazine
|
沃替西汀杂质F
|
508233-76-9
|
C18H22N2S
|
|
Vortioxetine Imp.E
|
沃替西汀杂质E
|
508233-77-0
|
C18H22N2S
|
|
Vortioxetine Impurity 3
|
沃替西汀杂质3
|
508233-82-7
|
C17H20N2S
|
|
4-[2-(4-methylphenyl)sulfanylphenyl]piperidine
|
4-[2-(4-甲基苯基磺酰基)-苯基]哌啶
|
508233-95-2
|
C18H21NS
|
|
1H-Indole-5-methanol,-alpha--(aminomethyl)-(9CI)
|
2-氨基-1-(1H-吲哚-5-基)乙醇
|
508233-98-5
|
C10H12N2O
|
|
Benzenamine, 2-(3-methyl-1-piperazinyl)- (9CI)
|
|
508234-01-3
|
C11H17N3
|
|
ethyl 4-(4-(hydroxymethyl)piperidin-1-yl)benzoate
|
508234-07-9
|
508234-07-9
|
C15H21NO3
|
|
N-Biotinyl-N’-(N-Boc-S-trityl)cysteinyl Ethylenediamine
|
N-Biotinyl-N’-(N-Boc-S-trityl)cysteinyl Ethylenediamine
|
508234-94-4
|
C39H49N5O5S2
|
|
1H-Imidazole,1-ethenyl-5-nitro-(9CI)
|
|
508235-09-4
|
C5H5N3O2
|
|
ethyl 4-oxo-1-propylcyclohexanecarboxylate
|
4-氧代-1-丙基环己烷甲酸乙酯
|
508235-11-8
|
C12H20O3
|
|
2,3-Difluoro-4-methylphenylboronicacid
|
2,3-二氟-4-甲基苯硼酸
|
508235-16-3
|
C7H7BF2O2
|
|
Pyrrolo[1,2-a]pyrazine, octahydro-7-methoxy-, (7R,8aS)- (9CI)
|
Pyrrolo[1,2-a]pyrazine, octahydro-7-methoxy-, (7R,8aS)- (9CI)
|
508241-13-2
|
C8H16N2O
|
|
Pyrazino[2,1-c][1,4]oxazine, octahydro-, (9aR)- (9CI)
|
(9AR)-八氢吡嗪并[2,1-C][1,4]恶嗪
|
508241-14-3
|
C7H14N2O
|
|
2,4-Cyclopentadiene-1-carboxaldehyde,2,5-dichloro-(9CI)
|
|
508242-23-7
|
C6H4Cl2O
|
|
OroticAcid(VitamineB13)
|
|
508897-69-9
|
|
|
2,2-DIFLUOROCYCLOPROPYLMETHANOL
|
2,2-二氟环丙基甲醇
|
509072-57-5
|
C4H6F2O
|
|
Cyclopropanemethanol, 2,2-difluoro-3-methyl-, acetate (9CI)
|
|
509072-65-5
|
C7H10F2O2
|
|
Cyclopropanemethanol, 2,2-difluoro-alpha-methyl-, acetate (9CI)
|
|
509072-71-3
|
C7H10F2O2
|
|
TERT-BUTYL 4-(4-NITROBENZOYL)TETRAHYDRO-1(2H)-PYRAZINECARBOXYLATE
|
4-(4-硝基苯甲酰基)哌嗪-1-羧酸叔丁酯
|
509073-62-5
|
C16H21N3O5
|
|
3-(broMoMethyl)benzaMide
|
3-溴甲基-苯甲酰胺
|
509073-67-0
|
C8H8BrNO
|
|
Citric acid Clarithromycin
|
柠檬酸克拉霉素
|
509074-22-0
|
C44H77NO20
|
|
Valdecoxib IMpurity F
|
4-(5-甲基-3-苯基-4-异恶唑)苯磺酰氯
|
509074-26-4
|
C16H12ClNO3S
|
|
1H-Imidazole-1-acetaldehyde,alpha-methyl-,oxime,[C(E)]-(9CI)
|
|
509075-40-5
|
C6H9N3O
|
|
4H-1,2,4-Triazole-4-acetaldehyde,alpha-methyl-,oxime,[C(E)]-(9CI)
|
|
509075-43-8
|
C5H8N4O
|
|
Ethanol, 2-[2-(2-piperazinyl)ethoxy]- (9CI)
|
|
509076-90-8
|
C8H18N2O2
|